Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lyo-FMT for Primary CDI
NCT05709184Recruiting
- Sponsor
- Rambam Health Care Campus
- Start
- Nov 2023
- Primary completion
- Nov 2025
- Countries
- 6
01
Overview
Randomised, single-blind trial in Clostridioides difficile infection (CDI) (2 arms), sponsored by Rambam Health Care Campus. Primary endpoint: Recurrence of Clostridioides Difficile Infection at 8 weeks. Started Nov 2023; status: recruiting.
02
Conditions
Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT05709184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05709184.